Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming ...

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

The pharmaceutical sector on both sides of the Atlantic appeared to have dodged Trump’s tariffs last night, as pharmaceutical products were among several categories exempted from reciprocal tariffs, ...

Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the ...

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic, according ...

India, known for its generic drug industry, is rapidly transforming into a major hub for the global weight management ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

The strategic move aims to unify mandates, clarify institutional roles, and strengthen integration among relevant government ...